Cellular immunity and hepatitis-associated, Australia antigen liver disease.

[1]  D. Rubenstein,et al.  New antigen-antibody system in Australia-antigen-positive hepatitis. , 1971, Lancet.

[2]  J. Nielsen,et al.  Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. , 1971, The New England journal of medicine.

[3]  G. C. Turner,et al.  SH (Australia) antigen in early life , 1971, Archives of disease in childhood.

[4]  A. A. Laiwah,et al.  Lymphocyte transformation by Australia antigen. , 1971, Lancet.

[5]  P. Stastny,et al.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. , 1971, Lancet.

[6]  K. Isselbacher,et al.  The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. , 1971, The New England journal of medicine.

[7]  S. Sherlock,et al.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. , 1971, Lancet.

[8]  A. Prince,et al.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. , 1971, Lancet.

[9]  L. Barker,et al.  Aquisition of hepatitis-associated antigen. Clinical features in young adults. , 1971, JAMA.

[10]  G. Bouvier.  The heterogeneity of Australia antigen. , 1971 .

[11]  K. Isselbacher,et al.  Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. , 1970, Lancet.

[12]  S. Sherlock,et al.  Hepatitis-associated Antigen and Antibody in Haemodialysis Patients and Staff , 1970, British medical journal.

[13]  R. Spears,et al.  Hepatitis-associated antigen (Australia antigen) in mother and infant. , 1970, The New England journal of medicine.

[14]  W. Szmuness,et al.  The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. , 1970, American journal of epidemiology.

[15]  S. Sherlock,et al.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. , 1970, Lancet.

[16]  S. Krugman,et al.  Viral hepatitis. New light on an old disease. , 1970, JAMA.

[17]  L. Barker,et al.  Transmission of serum hepatitis. , 1970, JAMA.

[18]  A. P. Waterson,et al.  Immune complexes in hepatitis. , 1969, Lancet.

[19]  R. Wright,et al.  Australia antigen in acute and chronic liver disease. , 1969, Lancet.

[20]  A. Zuckerman,et al.  Persistence of the Serum Hepatitis (SH-Australia) Antigen for Many Years , 1969, Nature.

[21]  Larsen Jh.  Immunological tolerance and the significance of cell-mediated immunity in virus infections. , 1969 .

[22]  M. Oldstone,et al.  PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION , 1969, The Journal of experimental medicine.

[23]  F. Burnet.  Measles as an index of immunological function. , 1968, Lancet.

[24]  M. Lechat,et al.  Association between lepromatous leprosy and Australia antigen. , 1967, Lancet.

[25]  D. Hungerford,et al.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. , 1967, Annals of internal medicine.

[26]  J. Sheagren,et al.  Impaired delayed hypersensitivity in patients with lepromatous leprosy. , 1966, Lancet.

[27]  A. Aisenberg.  Studies on delayed hypersensitivity in Hodgkin's disease. , 1962, The Journal of clinical investigation.

[28]  A. Sutnick,et al.  Australia antigen as a hepatitis virus. Variation in host response. , 1970, The American journal of medicine.

[29]  G. Fairley,et al.  Cellular resistance to tumours. , 1967, British medical bulletin.

[30]  A. Allison.  Cell-mediated immune responses to virus infections and virus-induced tumours. , 1967, British medical bulletin.